Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03304314

Multifocal Chromatic Pupilloperimetry in Patients With Pseudotumor Cerebri and Healthy Subjects.

Assessment of Pupillary Response and Visual Field Defects by Objective Multifocal Chromatic Pupillometer in Patients With Pseudotumor Cerebri and Healthy Subjects

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Sheba Medical Center · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

PTC(Pseudotumor cerebri) patients may develop increased Intracranial pressure (ICP) that can produces increased pressure around the distal optic nerve,which is likely followed by venule compression, ischemia, and loss of visual function.Vision loss in PTC is most commonly characterized by standard automated perimetry to measure peripheral visual field sensitivity. Pupillometry is a promising approach for functional assessment in PTC because it is noninvasive, objective, performed quickly with minimal patient cooperation needed. The feasibility of using chromatic multifocal pupillometry for assesment of PTC will be examined.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTobjective chromatic multifocal pupillometerobjective chromatic multifocal pupillometer (OCMP) enables objective and accurate measurement of pupillary responses to chromatic light at different wavelengths and light intensities and at different visual field locations.

Timeline

Start date
2017-11-03
Primary completion
2027-12-31
Completion
2027-12-31
First posted
2017-10-09
Last updated
2025-10-06

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT03304314. Inclusion in this directory is not an endorsement.